Wearable Devices
WLDS
1 hedge funds and large institutions have $405K invested in Wearable Devices in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 7 closing their positions.
567% more capital invested
Capital invested by funds: $60.8K → $405K (+$345K)
0.2% more ownership
Funds ownership: 0% → 0.2% (+0.2%)
86% less funds holding
Funds holding: 7 → 1 (-6)
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$488K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$24.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.1K |
| 3 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$6.9K |
| 4 |
Goldman Sachs
New York
|
-$6.32K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$6K |
WLDS Hedge Fund Activity: Q4 2024 in Review
1 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Wearable Devices (WLDS) for Q4 2024, worth a combined $405K — up 567% from $60.8K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of WLDS and 1 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $488K. The largest seller was Citadel Advisors, exiting entirely with an estimated $24.6K sold.
- 1 institutional investor held Wearable Devices (WLDS) as of Q4 2024, down from 7 in Q3 2024.
- Funds reported $405K of Wearable Devices stock for Q4 2024, up 567% quarter-over-quarter.
- 1 fund opened new Wearable Devices positions in Q4 2024 and 7 closed out, a net change of -6 holders.
- The largest Wearable Devices buyer in Q4 2024 was Armistice Capital, an estimated $488K added.
- The largest Wearable Devices seller in Q4 2024 was Citadel Advisors, an estimated $24.6K sold.
Based on aggregated 13F filings for Q4 2024.